Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
ClinicalTrials.gov study NCT02603705. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Moderating Roles of Social Support, Coping Resources and Personality and Mediating Role of Self-esteem on the Impact of Cognitive Deficit on Neuropsychiatric Symptoms Among Persons With Mild Cogni
ClinicalTrials.gov study NCT04085107. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT06085521. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT04179760. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis
ClinicalTrials.gov study NCT03478280. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Melatonin Treatment for Newborn Infants With Moderate to Severe Hypoxic Ischemic Encephalopathy
ClinicalTrials.gov study NCT01904786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pilot Study to Test the Effects of Arctiva on Mild to Moderate Eczema
ClinicalTrials.gov study NCT05918237. IPD Sharing: NO. Countries: 1. Publications: 0.
Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease
ClinicalTrials.gov study NCT00294112. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate
ClinicalTrials.gov study NCT06199336. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Efficacy of ASC40 (Denifanstat) Tablets in the Treatment of Patients With Moderate to Severe Acne Vulgaris
ClinicalTrials.gov study NCT06192264. IPD Sharing: NO. Countries: 1. Publications: 0.
A Botanical Skin Care Regimen on Mild to Moderate Acne and the Microbiome
ClinicalTrials.gov study NCT05271487. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of a Combination of Treatment of Reginmune Capsule and Immunofree Tablets in the Treatment of Mild to Moderate COVID-19 Patients
ClinicalTrials.gov study NCT04494204. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Drug-Drug Interaction of Pyrotinib With a Moderate CYP3A Inducer
ClinicalTrials.gov study NCT04680091. IPD Sharing: NO. Countries: 1. Publications: 0.
An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02808780. IPD Sharing: Not stated. Countries: 9. Publications: 0.
A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response to Methotrexate
ClinicalTrials.gov study NCT04204603. IPD Sharing: UNDECIDED. Countries: 5. Publications: 0.
Clinical and Cost-effectiveness of an Online Self-help Intervention and a Face-to-face Intervention Versus Usual Care in Mothers at Moderate Risk for Perinatal Depression
ClinicalTrials.gov study NCT07027761. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT05735483. IPD Sharing: YES. Countries: 13. Publications: 0.
A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT06077331. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertens
ClinicalTrials.gov study NCT01878201. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT01770834. IPD Sharing: Not stated. Countries: 4. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.